Shigellosis in Southeast Asia: A systematic review and meta-analysis
- PMID: 36792021
- DOI: 10.1016/j.tmaid.2023.102554
Shigellosis in Southeast Asia: A systematic review and meta-analysis
Abstract
Background: Southeast Asia is attractive for tourism. Unfortunately, travelers to this region are at risk of becoming infected with Shigella. We conducted a meta-analysis to provide updates on Shigella prevalence in Southeast Asia, along with their serogroups and serotypes.
Methods: We conducted a systematic search using PubMed, EMBASE, and Web of Science for peer-reviewed studies from 2000 to November 2022. We selected studies that detected Shigella in stools by culture or polymerase chain reaction (PCR). Two reviewers extracted the data using a standardized form and performed quality assessments using the Joanna Briggs Institute checklist. The random effects model was used to estimate the pooled prevalence of Shigella.
Results: During our search, we identified 4376 studies. 29 studies (from six Southeast Asian countries) were included in the systematic review, 21 each in the meta-analysis of the prevalence of Shigella (Sample size: 109545) and the prevalence of Shigella serogroups. The pooled prevalence of Shigella was 4% (95% CI: 4-5%) among diarrhea cases. Shigella sonnei was the most abundant serogroup in Thailand (74%) and Vietnam (57%), whereas Shigella flexneri was dominant in Indonesia (72%) and Cambodia (71%). Shigella dysenteriae and Shigella boydii were uncommon (pooled prevalence of 1% each). The pooled prevalence of Shigella was 5% (95% CI: 4-6%) in children aged <5 years. The pooled prevalence showed a decreasing trend comparing data collected between 2000-2013 (5%; 95% CI: 4-6%) and between 2014-2022 (3%; 95% CI: 2-4%). Shigella prevalence was 6% in studies that included participants with mixed pathogens versus 3% in those without. Shigella flexneri serotype 2a was the most frequently isolated (33%), followed by 3a (21%), 1b (10%), 2b (3%), and 6 (3%).
Conclusions: This study provides compelling evidence for the development of effective Shigella vaccines for residents of endemic regions and travellers to these areas.
Keywords: Diarrhea; Dysentery; Shiga toxin; Shigella flexneri; Shigella sonnei; Shigella vaccine; Travel.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Similar articles
-
Epidemiology of Shigella species and serotypes in children: a retrospective substudy of the MAL-ED observational birth cohort study.Lancet Microbe. 2025 Jun;6(6):101064. doi: 10.1016/j.lanmic.2024.101064. Epub 2025 Mar 26. Lancet Microbe. 2025. PMID: 40157382 Free PMC article.
-
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079. Health Technol Assess. 2024. PMID: 39046101 Free PMC article.
-
Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis.Lancet Glob Health. 2017 Dec;5(12):e1235-e1248. doi: 10.1016/S2214-109X(17)30392-3. Lancet Glob Health. 2017. PMID: 29132613 Free PMC article.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Prevalence of Shigella species and antimicrobial resistance patterns in Africa: systematic review and meta-analysis.BMC Infect Dis. 2024 Oct 29;24(1):1217. doi: 10.1186/s12879-024-09945-2. BMC Infect Dis. 2024. PMID: 39472797 Free PMC article.
-
Shigella sonnei: epidemiology, evolution, pathogenesis, resistance and host interactions.Nat Rev Microbiol. 2025 May;23(5):303-317. doi: 10.1038/s41579-024-01126-x. Epub 2024 Nov 27. Nat Rev Microbiol. 2025. PMID: 39604656 Review.
-
The fusion subunit vaccine L-DBF protects aged mice against heterologous lethal Shigella challenge after prior exposure.Front Immunol. 2025 Jun 5;16:1586537. doi: 10.3389/fimmu.2025.1586537. eCollection 2025. Front Immunol. 2025. PMID: 40539050 Free PMC article.
-
Genetic evidence strengthens the bidirectional connection between gut microbiota and Shigella infection: insights from a two-sample Mendelian randomization study.Front Microbiol. 2024 Mar 1;15:1361927. doi: 10.3389/fmicb.2024.1361927. eCollection 2024. Front Microbiol. 2024. PMID: 38495509 Free PMC article.
-
Prevalence of common diarrheagenic enterobacteriaceae in Iran (2000-2023): a systematic review and meta-analysis.BMC Gastroenterol. 2025 Jan 29;25(1):43. doi: 10.1186/s12876-025-03634-3. BMC Gastroenterol. 2025. PMID: 39881226 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources